; Skip to Main Content

CLEARPATH:

Early Detection of Diabetic Risk

The CDC reports that 27.8% of people with diabetes are not diagnosed. People with diabetes are at higher risk of serious health complications INCLUDING blindness.

Now offered at Piedmont EyeCare

CLEARPATH technology, developed by Harvard University, provides a six second scan to indicate if you’re at risk for diabetes up to 7 years before symptoms display! Early detection and intervention that lead to lifestyle changes reduce the risk of diabetic retinopathy by 76%!

ClearPath device picture

How CLEARPATH Works

This device scans the eye with a blue light, measuring the intensity of light emitted by the eye. When there’s too much sugar in a patient’s body, sugar molecules start binding to proteins in the lens of the eye. A higher measure corresponds to higher levels of glucose build-up in the eye.

Ask our staff about this important test and if its right for you!